Bruce K. Patterson, M.D.
Founder
bruce@invirion.com
Dr. Patterson received his undergraduate training in molecular
biology from the University of Michigan in Ann Arbor.
He then went on to Northwestern University Medical School
for training in medicine. During the early stages of the
AIDS epidemic, Dr. Patterson began investigating cellular
reservoirs of HIV-1 using molecular and in situ technology
patented in his laboratory. Dr. Patterson went on to a
residency in Pathology focusing on viral pathogenesis.
While in his residency, Dr. Patterson determined that
enough HIV virus was present in infected individuals to
account for the massive destruction of the immune system.
This paradigm altering work was published in Science in
1993. Dr. Patterson later was named Chief Resident of
Pathology at Northwestern Memorial Hospital. Dr. Patterson
has authored over 80 manuscripts and book chapters and
he continues his work on HIV-1 pathogenesis and reservoirs
at Stanford University School of Medicine. Dr. Patterson
currently serves as Director of Virology at Stanford University
Hospitals and Clinics.
John M. Drews
President and General Counsel
johndrews@invirion.com
John Drews is the President, General Counsel and managing
member of Invirion Diagnostics, LLC and its affiliates.
Mr. Drews is an attorney with 15 years of experience in
the areas of complex licensing and contract negotiations,
intellectual property and commercial litigation. Mr. Drews
also has over 20 years of management and consulting experience
in various manufacturing and distribution industries.
Jeff Harvey
Vice President of Global Sales
jeffharvey@invirion.com
Jeff Harvey joined Invirion Diagnostics, LLC as Vice President,
Global Sales in May 2006. Jeff is a senior sales and marketing
executive with over 22 years of experience in the biomedical
industry. Prior to joining Invirion, Jeff was a Vice President
at Guava Technologies, Inc., where he initially established
and managed a very successful, worldwide sales and marketing
team for the company and subsequently spearheaded the
establishment of Guava’s highly regarded global
HIV/AIDS program, to provide affordable solutions for
monitoring HIV patients in resource limited settings in
Africa and elsewhere. Jeff also spent several years in
management positions with BIO-RAD, as the manager of their
Flow Cytometry Business unit and began his career with
an 8-year stint in key roles at Becton Dickinson, where
his most recent position was managing their Clinical Systems
business. Jeff was educated at the University of Iowa,
completing both the undergraduate and medical college
programs there, and performed several years of research
in immunology, prior to moving into the biomedical industry
where he has since remained. |
|
|
|
